Parker Institute for Cancer Immunotherapy
Deals on record
1
Common Fundraising Type
Series C
ArsenalBio
Programmable cell therapy
Arsenal Biosciences, Inc. is a clinical-stage company developing programmable T cell therapies for solid tumor cancers using a computationally driven approach.